Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

43 results
Display

Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap

Wang SY

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Correspondence on Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune tolerant phase”

Yoo JJ, Kim SG

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future

Chuah KH, Chan WK

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The current trends in the health burden of primary liver cancer across the globe

Konyn P, Ahmed A, Kim D

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed

Kasper P, Demir M, Steffen HM

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease – who and how?

Teng ML, Tan DJH, Ng CH, Huang DQ

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences

Yang T, Wang MD, Xu XF, Li C, Wu H, Shen F

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The clinical management of hepatocellular carcinoma in China: Progress and challenges

Shan S, Jia J

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?

Jang H, Kim W

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma

Kim DY

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Systemic therapy in advanced hepatocellular carcinoma

Ahn JC, Tran NH, Yang JD

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Letter regarding “Long-term prognosis and the need for histologic assessment of chronic hepatitis B in the serological immune-tolerant phase”

Chu CM, Liaw YF

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease

Song BG, Sinn DH

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The imitator of immune-tolerant chronic hepatitis B: A killer in disguise

Hur MH, Lee JH

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?

Park MK, Kim YJ

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review

Jin YJ

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future

Alnimer L, Noureddin M

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The latest global burden of liver cancer: A past and present threat

Oh JH, Jun DW

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Changing the nomenclature from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease is more than a change in terminology

Yoon EL, Jun DW

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The growing burden of non-alcoholic fatty liver disease on mortality

Cho JY, Sohn W

CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr